Enbrel etanercept TNF inhibitor: Phase II/III data; marketed

A combination of Enbrel and methotrexate was tested in 89 patients in a 24-week Phase II/III trial. A total of 71 percent of patients in the combination group met

Read the full 290 word article

How to gain access

Continue reading with a
two-week free trial.